Multiple biopharmaceutical collaborations were reached during the China International Import Expo, involving various fields such as hepatitis B and women's health

智通財經
2024.11.09 20:32
在第七屆中國國際進口博覽會期間，生物醫藥產業多項合作達成，涉及乙肝、慢阻肺等多個疾病領域，特別是在世界衞生組織提出到 2030 年消除乙肝、我國到 2030 年達到全面消除麻風危害目標等方面，多項合作助力目標的實現。葛蘭素史克與中國肝炎防治基金會簽署了慢性乙型肝炎疾病長期管理項目戰略合作備忘錄，以數智化手段賦能患者管理，探索院內院外創新管理模式，共同助力實現世界衞生組織 2030 年消除乙肝目標。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.